Insider Trading History of Windsor James Brian

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Windsor James Brian since 2019. This trader's CIK number is 1790933. At the time of last reporting, Windsor James Brian was the See Remarks of Rein Therapeutics, Inc.. (stock ticker symbol RNTX). Also see all insider trading activities at Rein Therapeutics, Inc..

Note that in the past WINDSOR JAMES BRIAN also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Tff Pharmaceuticals, Inc. (TFFP) by Windsor James Brian

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 TFFP 0 $0 25,000 $395,000 25,000 $62,500
2019 TFFP 5,000 $25,000 0 $0 0 $0

Yearly summary of insider trading at Rein Therapeutics, Inc. (RNTX) by Windsor James Brian

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 RNTX 25,000 $25,000 0 $0 0 $0
2024 RNTX 400 $898 0 $0 0 $0
2023 RNTX 5,301 $10,747 0 $0 0 $0


Insider trading activities at 2 companies by Windsor James Brian:

1. Tff Pharmaceuticals, Inc. (TFFP)

2. Rein Therapeutics, Inc. (RNTX)

Table 1. Insider trading of Tff Pharmaceuticals, Inc. (TFFP) by Windsor James Brian

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-12-07 TFFP Sale 25,000 15.80 395,000
2020-12-07 TFFP Option Ex 25,000 2.50 62,500
2019-10-25 TFFP Buy 5,000 5.00 25,000

Table 2. Insider trading of Rein Therapeutics, Inc. (RNTX) by Windsor James Brian

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-04-30 RNTX Buy 25,000 1.00 25,000
2024-12-05 ALRN Buy 400 2.25 898
2023-12-15 ALRN Buy 225 3.37 758
2023-11-20 ALRN Buy 5,076 1.97 9,989

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Windsor James Brian (See Remarks of Rein Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.